Hey there! Let’s chat about Moderna’s stock – it’s been quite a rollercoaster ride, hasn’t it?
Since May 2024, Moderna’s been on a pretty steep downhill slide, losing a whopping 79% of its value in just 5 months. Ouch! But hold onto your hats, because today things got interesting.
On heavy trading volume, Moderna’s stock showed signs of life, establishing a new trend towards its 200-day moving average. This could be the turnaround we’ve been waiting for!
Now, I’m not one to make promises, but if you’re looking for a stock that might outperform the market in 2025, Moderna’s looking like a solid candidate. We’re talking potential gains of 26% in just 3 months from today’s close, and – get this – a possible 90% increase in one year. Pretty exciting, right?
Here’s something else to keep an eye on: a new upward time cycle is expected to kick off at the end of January 2025. This could give Moderna’s stock an extra boost, potentially lasting until the first week of March 2025.
If things play out as expected, we might see the stock hit a first target around $65. Not too shabby!
But hey, as much as I love talking stocks, remember I’m just sharing information here. Always a good idea to chat with your financial advisor before making any big moves. They know your specific situation best.
What do you think? Are you feeling bullish about Moderna’s prospects for 2025?
IMPORTANT DISCLAIMER: This information is for educational purposes only and does not constitute financial advice. Investing involves risks, including potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Market conditions change frequently, and individual circumstances vary. This content should not be construed as a recommendation to buy, sell, or hold any specific security.